Qube Research & Technologies (QRT)’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TLIS Stock Details TLIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$18	–	4338
2024 Q2	$18	Hold	2	–	–	﹤0.01%	3587
2024 Q1	$18	Hold	2	–	–	﹤0.01%	4270
2023 Q4	$15	Hold	2	–	–	﹤0.01%	4149
2023 Q3	$12	Buy	+2	New	+$14	﹤0.01%	3915
2022 Q4	–	Sell	-671	Closed	-$7K	–	3107
2022 Q3	$7K	Sell	671 -66	-9%	-$835	﹤0.01%	2386
2022 Q2	$9K	Sell	737 -2,427	-77%	-$38.4K	﹤0.01%	2330
2022 Q1	$67K	Sell	3,164 -780	-20%	-$27K	﹤0.01%	2140
2021 Q4	$237K	Buy	3,944 +2,391	+154%	+$179K	﹤0.01%	1904
2021 Q3	$146K	Buy	+1,553	New	+$207K	﹤0.01%	1726

Other funds holding TLIS

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TLIS Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q3 2024, closing a stake of 2 shares — an estimated $18 sold.

Qube Research & Technologies (QRT) first reported a position in TLIS in Q3 2021 and held it in 9 quarters. The position peaked at $237K in Q4 2021. 2 funds tracked by Wall St. Rank hold TLIS as of Q3 2024.

Qube Research & Technologies (QRT) reported no remaining Talis Biomedical Corporation Common Stock position as of Q3 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 2 Talis Biomedical Corporation Common Stock shares in Q3 2024, an estimated $18.
Qube Research & Technologies (QRT) first reported a position in Talis Biomedical Corporation Common Stock in Q3 2021 and held it in 9 quarters.
Qube Research & Technologies (QRT)'s Talis Biomedical Corporation Common Stock position peaked at $237K in Q4 2021.
2 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.